Market forecast: Sunny skies for contract manufacturers

Contract manufacturing is where it's at, at least through 2015. Global Industry Analysts projects a $41-billion market, thanks in part to the "huge number" of biotechs that lack production operations. The analysts expect demand for liquid dosage form services to rise six percent annually. Services for solid dosage forms are expected to be the largest segment. GIA release

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.